Reducing Alcohol Use among Black Men: Barbershop SBIRT

减少黑人饮酒:理发店 SBIRT

基本信息

  • 批准号:
    10436494
  • 负责人:
  • 金额:
    $ 64.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

SUMMARY – PROJECT 3 Unhealthy drinking is considered one of the top 10 public health concerns in the United States.1 Not only has heavy drinking been linked to poorer overall health, it is responsible for about 88,000 deaths and 2.5 million years of potential life lost in the United States each year.2 Men exposed to social disadvantage, such as Black men living in poverty, are more likely to consume more alcohol.3–5 Indeed, in Arkansas, a state with high rates of unhealthy drinking, Black men who make less than $35,000 are more likely to report heavy drinking (4 or more drinks a day) and consume more drinks when binge drinking.6 Further, the negative impacts of unhealthy drinking may be worse for Black men. Black men who report consuming large amounts of alcohol often experience more severe health outcomes and more negative social consequences when compared to other ethnic groups.7–11 Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based, multilevel, integrated, public health approach to the delivery of early intervention services for individuals at risk for risky drinking, and the timely referral to more intensive treatment for those who have substance abuse disorders.12–14 SBIRTs have been effectively implemented in both primary care and emergency care settings15. However, structural barriers to care (i.e., insurance status, culturally competent services, racism and discrimination, etc.) may impede Black men's access to evidence-based care for unhealthy drinking located in medical settings.16 Given the increased risk for mortality and morbidity associated with unhealthy drinking among Black men living in poverty, coupled with the more harmful health consequences of unhealthy drinking for Black men, improving equitable access to evidence-based care by implementing care into community settings that Black men are more likely to access is urgently needed. Thus, the goals of this proposed Hybrid Type 2 pragmatic effectiveness-implementation trial are to: 1) test the effectiveness of a previously developed, evidence-based SBIRT intervention (Barbershop Talk) for low income African American men; and 2) generate the scientific evidence needed to disseminate SBIRTs to “real world” settings. Data from this study will further our understanding on how to reduce the risk of alcohol attributable morbidity and mortality among Black men living in poverty. Data will also improve our understanding of strategies that can improve implementation of evidence-based care models in non-clinical settings; thus, extending the reach of evidence-based care to communities with the highest need.
摘要 - 项目3 不健康的饮酒被认为是美国十大公共卫生问题之一。1不仅有 大量饮酒与整体健康状况较差有关,造成约88,000人死亡和250万 每年在美国丧生的多年潜在生命。2男子接触社会灾难,例如黑人 生活在贫困中的男性更有可能消耗更多的酒精。3-5的确在阿肯色州,一个率高的州 不健康的饮酒,少于35,000美元的黑人更有可能报告大量饮酒 (每天有4杯或更多饮料)并在暴饮暴食时食用更多饮料。6此外,负面影响 对于黑人来说,不健康的饮酒可能会更糟。报告报告大量酒精的黑人 与 其他种族群体。7-11筛查,简短干预和对治疗(SBIRT)的转诊(SBIRT)是基于证据的, 多级,综合的公共卫生方法,用于为处于危险的个人提供早期干预服务 为了饮用风险,以及及时转介到那些滥用毒品的人 在初级保健和急诊环境中有效地实施了12-14个SBIRT15。 但是,护理的结构性障碍(即保险状况,具有文化胜任的服务,种族主义和 歧视等)可能会阻碍黑人获得不健康饮酒的循证护理 16鉴于与不健康有关的死亡率和发病率的风险增加 生活在贫困中的黑人中喝酒,再加上不健康的健康后果 为黑人喝酒,通过将护理实施到社区中,改善公平获得基于证据的护理 迫切需要黑人更有可能进入的设置。 这是这个拟议的杂种2型实用有效性试验的目标是:1)测试 先前开发的基于证据的SBIRT干预(理发店谈话)的有效性 非裔美国人; 2)生成将SBIRT传播到“现实世界”所需的科学证据 设置。这项研究的数据将进一步了解我们如何降低酒精风险的理解 生活在贫困中的黑人的发病率和死亡率。数据还将提高我们对策略的理解 这可以改善在非临床环境中基于证据的护理模型的实施;因此,扩展 向具有最高需求的社区提供基于证据的护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tiffany Francine Haynes其他文献

Tiffany Francine Haynes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tiffany Francine Haynes', 18)}}的其他基金

Reducing Alcohol Use among Black Men: Barbershop SBIRT
减少黑人饮酒:理发店 SBIRT
  • 批准号:
    10494218
  • 财政年份:
    2021
  • 资助金额:
    $ 64.65万
  • 项目类别:
Reducing Alcohol Use among Black Men: Barbershop SBIRT
减少黑人饮酒:理发店 SBIRT
  • 批准号:
    10657718
  • 财政年份:
    2021
  • 资助金额:
    $ 64.65万
  • 项目类别:
Addressing Emotional Wellness among COVID-19 informal first-responders: REJOICE-P
解决 COVID-19 非正式急救人员的情绪健康问题:REJOICE-P
  • 批准号:
    10197493
  • 财政年份:
    2016
  • 资助金额:
    $ 64.65万
  • 项目类别:
Reducing depressive symptoms among rural African Americans: REJOICE.
减少农村非裔美国人的抑郁症状:REJOICE。
  • 批准号:
    9129416
  • 财政年份:
    2016
  • 资助金额:
    $ 64.65万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 64.65万
  • 项目类别:
Germline Genetic Modifiers of Radiation Response
辐射反应的种系遗传修饰剂
  • 批准号:
    10741022
  • 财政年份:
    2023
  • 资助金额:
    $ 64.65万
  • 项目类别:
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacks
OSA 治疗对黑人睡眠依赖性记忆和血液生物标志物的影响
  • 批准号:
    10740142
  • 财政年份:
    2023
  • 资助金额:
    $ 64.65万
  • 项目类别:
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
  • 批准号:
    10554474
  • 财政年份:
    2023
  • 资助金额:
    $ 64.65万
  • 项目类别:
Long Term Effectiveness of Uterine Sparing Fibroid Treatments
保留子宫肌瘤治疗的长期有效性
  • 批准号:
    10656850
  • 财政年份:
    2023
  • 资助金额:
    $ 64.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了